Future management of herpesvirus infections

P D Griffiths1

  • 1Department of Virology, Royal Free Hospital School of Medicine, London, United Kingdom.

Insights

Clinical studies on herpesviruses offer intervention strategies like infection prevention and treatment. Future research should combine sequential interventions for better patient outcomes against herpesvirus infections.

Area of Science:

  • Virology
  • Infectious Diseases
  • Clinical Research

Background:

  • Herpesviruses are a significant cause of human disease.
  • Existing clinical investigations have elucidated herpesvirus replication and pathogenesis.
  • Current interventions target initial infection, reactivation, viral suppression, and disease treatment.

Purpose of the Study:

  • To highlight the need for sequential intervention studies in managing herpesvirus infections.
  • To propose a strategy for optimizing patient care by combining different antiviral therapies.
  • To emphasize the importance of refining clinical trial designs with advancements in diagnostics and understanding of pathogenic mechanisms.

Main Methods:

  • Review of existing clinical investigations on herpesvirus interventions.
  • Conceptual framework for sequential intervention trials.
  • Discussion on the continuous refinement of clinical trial designs.

Main Results:

  • Various intervention strategies (prophylaxis, suppression, pre-emptive therapy, treatment) have shown efficacy against different herpesviruses.
  • Sequential interventions offer a promising approach to improve outcomes for patients who do not respond to single therapies.
  • Advancements in diagnostics and understanding of pathogenesis are crucial for designing effective trials.

Conclusions:

  • Combining sequential antiviral interventions can potentially reduce the burden of herpesvirus infections in susceptible populations.
  • Clinical trial designs must evolve with scientific progress in herpesvirus research.
  • Further research is needed to validate the efficacy of sequential intervention strategies.

Related Concept Videos

Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Herpes01:28

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...